Related Experiment Videos
[Thrombocyte receptors: current views and therapeutic options]
R J Peters1, A H Moons, H R Büller
1Afd. Cardiologie, Academisch Medisch Centrum/Universiteit van Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|October 20, 1999
Summary
Platelet receptors, like glycoprotein (Gp) Ib and Gp IIb/IIIa, are crucial for blood clot formation. Understanding these receptors improves treatment for cardiovascular diseases.
Area of Science:
- Hematology
- Biochemistry
- Molecular Biology
Context:
- Platelets (thrombocytes) play a vital role in hemostasis, preventing bleeding after vascular injury.
- Platelet adhesion and activation involve specific membrane receptors, notably glycoprotein (Gp) Ib binding to Von Willebrand factor.
Purpose:
- To elucidate the function of thrombocyte receptors in platelet adhesion, activation, and aggregation.
- To highlight the significance of Gp IIb/IIIa receptor activation by agonists and its role in platelet aggregation.
Summary:
- Platelet adhesion is mediated by receptors like Gp Ib, while activation by agonists leads to shape change and Gp IIb/IIIa receptor activation.
- Activated Gp IIb/IIIa receptors facilitate platelet aggregation by binding plasma proteins such as fibrinogen.
- Knowledge of these receptors is key to understanding diseases involving platelet aggregation.
Impact:
- Informs the development and application of antiplatelet therapies, particularly Gp IIb/IIIa antagonists.
- Demonstrates the efficacy of Gp IIb/IIIa antagonists, when combined with aspirin, for coronary artery disease treatment.